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Abstract 
We evaluated the role of protein phosphorylation in CAMP-mediated amylase exocytosis from parotid acinar cells by using H89, a new protein 
kinase A (PKA) inhibitor, which is more lipophilic and 25 times more potent than H8. In our previous studies, H8 markedly inhibited protein 
phosphorylation without decreasing amylase release [Takuma, T. (1988) Biochem. J. 256, 86778711. These findings were completely reproduced even 
in the small acini that were prepared by trypsin treatment before collagenase digestion. In the present study, however, H89 strongly inhibited both 
amylase release and protein phosphorylation in a dose-dependent manner. The inhibibory effect was specific for PKA at least up to 33 ,uM, since 
33 ,uM H89 did not block amylase release stimulated by PMA. H85, a closely related compound of H89 without inhibitory effect on PKA, did not 
prevent amylase release or protein phosphorylation at least up to 33 PM. These results suggest hat protein phosphorylation by PKA is involved 
in CAMP-mediated amylase exocytosis. The inhibition of protein phosphorylation by H8 might be insufficient or inadequate for blocking of amylase 
release. 
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1. Introduction 
Amylase release from parotid acinar cells is a good 
model of CAMP-mediated exocytosis [1,2]. Except for 
olfactory cells, where CAMP directly opens cation chan- 
nels [3], CAMP action is generally believed to be exerted 
through the activation of PKA, which in turn phospho- 
rylates specific proteins involved in the process of indi- 
vidual cell functions. In the regulation of exocytosis, 
however, the role of protein phosphorylation has yet to 
be established, although almost all secretory stimuli af- 
fect protein phosphorylation in the direction of increase 
and/or decrease [4,5]. A crucial role of PKA in the exocy- 
tosis from parotid acinar cells has long been postulated, 
since the activation of PKA and phosphorylation of 
some proteins were observed concurrently with amylase 
release evoked by ,&adrenergic agonists [6-121. How- 
ever, our previous studies suggested that protein phos- 
phorylation is not directly involved in amylase release, 
since PKA inhibitors H8 and peptide fragments of heat- 
stable protein kinase inhibitor (PKI-(5-24)-peptide) 
markedly inhibited protein phosphorylation without de- 
creasing amylase release stimulated by CAMP [ 13,141. In 
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addition, protein phosphatase inhibitors (okadaic acid 
and calyculin A) increased protein phosphorylation but 
inhibited, rather than enhanced, CAMP-mediated amy- 
lase release [15,161. 
Nevertheless, studies using various CAMP analogues 
strongly support the hypothesis that PKA is involved in 
the process of amylase exocytosis. Namely, (i) suitable 
pairs of site-selective CAMP analogues ynergistically in- 
creased amylase release [14,17]; and (ii) CAMP antago- 
nist Rp-CAMPS (Rp-adenosine 3’,5’-phosphorothioate) 
competitively inhibited amylase release stimulated by 
CAMP or isoproterenol [18]. Recently O’Sullivan and 
Jamieson [19] found that H89, a new PKA inhibitor, 
cleary blocked the stimulatory effect of CAMP on Ca”- 
induced amylase release from pancreatic acini. H89 is 
more lipophilic and 25 times more potent than H8 [20- 
22]. Thus, we have reexamined the effects of H8 and H89 
on amylase release and protein phosphorylation in pa- 
rotid acini. 
2. Experimental 
2. I. Materials 
H89, H85, and H8 were purchased from Seikagaku Kogyo (Tokyo, 
Japan). [“PlOrthophosphoric acid was from DuPont-Daiichi (Tokyo). 
Collagenase (CLS II) was from Worthington (Freehold, NJ, USA). 
Hyaluronidase (type I-S), trypsin (type III), trypsin inhibitor (type 
II-S), and phosphate-free Eagle’s minimum essential medium (MEM) 
were from Sigma (St. Louis, MO, USA). All other chemicals utilized 
were the highest grade commercially available. 
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2.2. Preparation of parotid acini 
Rat parotid acini were prepared as described previously [13-161. 
Briefly, parotid glands were minced finely and incubated for 60 min at 
37°C in Hanks’ balanced salt solution buffered with 20 mM Na-HEPES 
(pH 7.4) (HBSS-H) containing collagenase (130 unit/ml), hyaluronidase 
(0.25 mg/ml), and 0.1% BSA under 100% 0, in a metabolic shaker. 
After digestion, the acini were filtered through a nylon mesh, washed 
4 times with HBSS-H containing 0.1% BSA, and suspended in the same 
medium. Acini thus prepared are mentioned sometimes hereafter as 
large acini. 
The other type of acini was prepared according to the method de- 
scribed by Tanimura and Tojyo [23,24]. Briefly, finely minced parotid 
glands were incubated for 10 min in HBSS-H containing trypsin (0.5 
mg/ml) and 0.1% BSA. Tissue was washed once with Cal’- and Mg’+- 
free HBSS-H containing 2 mM EGTA and then incubated for 5 min 
with trypsin inhibitor (0.5 mg/ml) in the same medium. After the tissue 
had been washed with normal HBSS-H, it was further incubated for 20 
min in normal HBSS-H containing collagenase and hyaluronidase as 
described above. Dispersed acini were filtered through a nylon mesh, 
washed 4 times with HBSS-H containing 0.1% BSA, and suspended in 
the same medium. Acini thus prepared are referred to as small acini. 
2.3. Amylase release 
Parotid acini were preincubated for 15 min at 37°C with various 
protein kinase inhibitors or their vehicles and further incubated for 15 
min after the addition of secretory stimuli. Incubation was terminated 
by filtration through a glass fiber paper, and the medium was kept for 
assay of amylase released. For measurement of total amylase activity, 
acini were incubated with 0.2% Triton X-100 as above. Amylase activity 
was measured by the method of Bernfeld [25], and the released amylase 
activity was given as the percentage of the total activity. 
2.4. Protein phosphorylation 
Small acini were washed twice with phosphate-free MEM buffered 
with 40 mM Na-HEPES (pH 7.4) containing 0.1% BSA, and incubated 
for 60 min at 37°C in the same medium containing [“Plortho- 
phosphoric acid (0.2-0.3 mCi/ml). The acini were washed once with the 
same medium without [‘*P]orthophosphoric acid, preincubated for 
15 min with various protein kinase inhibitors, and further incubated for 
1.5 min after addition of I ,uM isoproterenol. After incubation, acini 
were homogenized with a solution of 0.3 M sucrose, 10 mM NaF, 
10 mM EDTA, 10 mM EGTA, and 10 mM K-phosphate (pH 6.8) in 
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a Teflon-glass homogenizer. The homogenates were centrifuged at 
750 x g for 10 min and 15,000 x g for 15 min at 4”C, and the resulting 
pellets were boiled with Laemmli buffer [26]. Electrophoresis was car- 
ried out on 15% polyacrylamide gel, and autoradiograms were prepared 
from dried gels by use of Fuji X-ray films. 
3. Results 
Although the Ki of H89 for PKA has been reported 
to be 48 nM in a cell-free assay system [20], up to 10 ,uM 
H89 had no effect on amylase release from intact parotid 
acini (large acini) stimulated by 1 PM isoproterenol. 
Above that concentration, however, H89 dose-depen- 
dently inhibited amylase release, and almost completely 
abolished the release at 100 ,LLM. The IC,, was approxi- 
mately 33 PM (Fig. 1). The inhibitory effect of H89 was 
more prominent in saponin-permeabilized acini. In these 
experiments acini were preincubated with H89 for the 
first 5 min without saponin, and then 5 min with 20,ug/ml 
saponin, and further incubated for 15 min after the addi- 
tion of 1 mM CAMP to Ca*+-free KC1 medium contain- 
ing 1 mM EGTA and 10 ,uM propranolol. Amylase re- 
lease was almost completely inhibited at 33 ,LLM H89, the 
ICsO value of which decreased to 10 ,uM (Fig. 1). In the 
permeabilized acini, however, higher concentrations of 
H89 markedly increased basal amylase release, suggest- 
ing H89 to have some effects on the secretory granule 
membrane. 
To make sure that the inhibitory effect of H89 results 
from the inhibition of PKA, we examined the effect of 
H85, which is a compound closely related to H89, but is 
more than 1000 times less potent for PKA inhibition 
om 
1-189 (PM) 
Fig. 1. Effect of H89 on amylase release from intact (left) and saponin-permeabilized (right) parotid acini. Parotid acini were preincubated at 37°C 
with various concentrations of H89 or its vehicle (1% DMSO) for 15 min in normal HBSS-H or for 10 min in Ca”-free KCI medium containing 
I mM EGTA, 10 PM propranolol, and 20 &ml saponin, and further incubated for 15 min after addition of 1 ,uM isoproterenol (+ISO) for intact 
acini or 1 mM CAMP (+cAMP) for permeabilized ones. Open symbols are H89 alone. Results are means + S.D. (n = 8). 
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Fig. 2. Effect of H85 on amylase release from parotid acini. Intact (left) and saponin-permeabilized (right) parotid acini were preincubated with various 
concentrations of H85 or DMSO for 15 min in normal HBSS-H or for 10 min in Ca”-free KC1 medium containing 1 mM EGTA, 10pM propranolol, 
and 20 &ml saponin, and further incubated for 15 min with 1 PM isoproterenol or 1 mM CAMP. Open symbols are H85 alone. Results are 
means f SD. (n = 8). 
than H89 [20]. As shown in Fig. 2, H85 had no inhibitory 
effect on amylase release up to 33 PM both in intact and 
saponin-permeabilized acini, but strongly blocked amy- 
lase release at 100 ,uM. 100 PM H85 also increased basal 
amylase release, as did H89. 
Next we examined whether or not the inhibitory effect 
of H89 is specific for CAMP-mediated amylase release. 
Fig. 3 shows that 33 ,uM H89 did not inhibit amylase 
release stimulated by 1 ,uM PMA (phorbol 1Zmyristate 
13 acetate), a direct activator of protein kinase C (PKC). 
The amylase release, however, was markedly inhibited 
by 100 PM H89, suggesting that the effect of 100 ,uM 
H89 is not necessarily specific for PKA. 
In our previous studies [13,14], H8 did not inhibit 
amylase release, although it markedly reduced protein 
phosphorylation. Parotid acini prepared by collagenase 
and hyaluronidase digestion are mainly large-complex 
acini. Thus, the decrease in protein phosphorylation and 
the normal amylase release might occur independently in 
different cells (e.g. peripheral cells and interior cells) 
within the large acini. In order to exclude this possibility, 
smaller acini were prepared by lo-min treatment with 
trypsin before collagenase digestion [23,24]. The small 
acini maintained responsiveness to isoproterenol and 8- 
chlorophenylthio-CAMP, a membrane-permeable CAMP 
analogue, but did not respond to CAMP in the presence 
of lo-20 &ml saponin even in the medium supple- 
mented with 1 mM Mg . ATP and 0.2 ,uM Ca*’ (data not 
shown). Therefore, we could not examine the effects of 
H8 and PKI-(5524)-peptide on amylase release from sap- 
onin-permeabilized small acini. 
Using the small intact acini, we reexamined the effect 
of H8 at higher concentrations and with longer preincu- 
bation than before [13,14]. As shown in Fig. 4, however, 
up to 400 ,uM H8 had no inhibitory effect on amylase 
release. In such acini, 10 ,uM H89 clearly inhibited amy- 
lase release (Fig. 4), although the IC,, value of H89 was 
almost same as with intact large acini (Fig. 1). 
Finally we examined the effects of protein kinase in- 
hibitors on protein phosphorylation in intact small acini 
stimulated by 1 PM isoproterenol. Fig. 5 shows that H89 
dose-dependently inhibited phosphorylation of 2 l- and 
26-kDa proteins in the 15,000 x g pellet fraction. Al- 
though inhibiting amylase release, 100 PM H85 hardly 
inhibited protein phosphorylation. Inversely, 200 ,uM 
H8 clearly decreased protein phosphorylation, as re- 
ported previously [ 13,141. 
4. Discussion 
In the present study H89 markedly inhibited both am- 
ylase release and protein phosphorylation in parotid 
acini stimulated by isoproterenol. The inhibitory effect 
of H89 was dose dependent and specific for PKA at least 
up to 33 ,uM, since 33 PM H89 did not inhibit amylase 
release induced by PMA. In addition, H85, a negative 
control of H89, which has similar Ki values for various 
protein kinases except for PKA [20], did not block amy- 
lase release up to 33 ,uM. These results strongly suggest 
that H89 inhibits CAMP-mediated amylase release 
through the inhibition of protein phosphorylation by 
32 
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Fig. 3. Effect of HS9 on amylase release from parotid acini stimulated 
by PMA. Intact acini were preincubated with various concentrations 
of HS9 for 15 min, and further incubated for 15 min with 1 ,uM PMA 
or its vehicle (DMSO). Resuls are means rf: SD. (n = 4). 
+ISO 
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Fig. 4. Effects of HS and HS9 on amylase release from intact small acini. The small acini were preincubated with various concentrations of H8 or 
HS9 for 15 min, and further incubated for 15 min with 1 PM isoproterenol. Results are means t SD. (n = 6). 
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PKA. This conclusion is quite consistent with previous 
findings that H89 clearly blocked the stimulatory effect 
of CAMP on Ca2’-induced amylase release from pancre- 
atic acini [19], but is completely inconsistent with our 
previous conclusion [I 3,143. 
Our current study, however, also confirmed our previ- 
ous findings that HS inhibited protein phosphorylation 
without decreasing amylase release [13,14]. The inhibi- 
tion of protein phosphorylation and the normal amylase 
release are very likely to occur in the same acinar cells, 
since these phenomena were observed even in the small 
acini prepared by trypsin treatment prior to coliagenase 
digestion (Figs. 4 and 5). There are several possible rea- 
sons why H8 did not block amylase release. Namely, (i) 
the inhibition of protein phosphorylation by H8 might 
be insufficient for a detectable decrease in amylase re- 
lease. This implies that a small increase in protein phos- 
phorylation is enough for the maximal amylase release, 
although amylase release and phosphorylation of 21- 
and 26-kDa proteins were well correlated in the absence 
of protein kinase inhibitors [14]. (ii) Whereas HX inhib- 
ited Zl- and 26kDa proteins, it would not block phos- 
phorylation of the unidentified proteins that is responsi- 
ble for exocytosis, as suggested by O’Sullivan and Jam- 
ieson [19]. This presumes that there are intracellular 
compartments of PKA and its substrates, which are ac- 
cessible for H89 but not for H8 because of their differ- 
ences in lipophilicity or other reasons. 
In the present study 100 ,uM H85 strongly blocked 
CAMP-mediated amylase release. This inhibitory effect 
is unlikely to be related to PKA, since the Ki of H85 for 
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Fig. 5. Effects of H89, H85, and H8 on protein phosphorylation in 
intact small acini stimulated by isoproterenol. The ‘ZP-labelled small 
acini were preincubated with lo-100yM H89,lOOflM H8.5, or 200yM 
H8 for 15 min in phosphate-free MEM, and further incubated for 15 
min after addition of 1 PM isoproterenol. Proteins in the 15,000 x g 
pellet fractions were separated by SDS-PAGE on 15% gel, and 
phosphorylated proteins were detected by autoradiography. CONT, 
1% DMSO alone; H89, 100 PM H89 alone; ISO, 1 PM isoproterenol 
alone; + H 10, + H 33, and + H 100 are 1clOOpM H89 plus 1 PM 
isoproterenol, respectively; + H85, 100 PM H85 plus 1 PM isoprotere- 
nol; + H-8, 200 PM H8 plus 1 PM isoproterenol. Arrows indicate 21 
and 26 kDa proteins. 
hardly inhibited protein phosphorylation evoked by iso- 
proterenol. Similarly the effect of H89 is not necessarily 
specific for PKA, since 100 ,uM H89 inhibited PMA- 
induced amylase release. Since H85 and H89 are struc- 
turally related, 100 PM H85 and H89 are very likely to 
share the same inhibitory mechanism that is presently 
unknown. As discussed above, the inhibition of amylase 
release by up to 33 ,LLM H89 is highly possible to be 
mediated by the inhibition of PKA. However, the possi- 
bility is not completely ruled out that H89 at lower than 
33 yM still maintains the unidentified inhibitory action 
of 100 ,uM H85 and H89, although 33 PM H89 did not 
inhibit PMA-mediated amylase release. 
Taken as a whole, the present results and previous 
findings in pancreatic acini [ 191 strongly support the con- 
clusion that protein phosphorylation by PKA is involved 
in the process of CAMP-mediated amylase exocytosis. In 
the two exocrine glands, however, the role of PKA in the 
exocytosis is not necessarily the same, since CAMP is the 
main stimulant for amylase release in parotid glands, 
whereas CAMP is a poor stimulant by itself but a modu- 
lator of Ca”-induced exocytosis in the pancreas. Any- 
way, the complete demonstration of the validity of this 
hypothesis demands data showing that amylase release 
is induced by direct introduction of PKA catalytic sub- 
units into acinar cells of those glands. 
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